Persist AI vs Decimal
Side-by-side comparison of AI visibility scores, market position, and capabilities
AI-powered long-acting injectable drug formulation platform cutting development from 5 years to 2; $12M Series A with Eli Lilly investment competing in microsphere CDMO development.
About
Persist AI is a pharmaceutical formulation company operating an AI-powered drug formulation platform with robotic cloud lab capabilities — specializing in the development of long-acting injectable (LAI) microsphere formulations that can deliver drug release over weeks or months (up to one year), addressing the adherence challenges of daily oral medications for chronic conditions including mental health, addiction, HIV, contraception, and oncology. Founded in 2022 and backed by $16 million including a $12 million Series A led by Spero Ventures with participation from Eli Lilly, Persist AI accelerates drug development timelines by approximately 50%, reducing typical 5-year formulation development to 2 years.\n\nPersist AI's platform combines AI-driven formulation design (predicting which polymer/drug/process combinations will achieve target release profiles) with robotic laboratory execution (automated synthesis and testing of formulation candidates) and analytics that identify optimal formulations faster than traditional trial-and-error approaches. The microsphere technology encapsulates drug molecules in biodegradable polymer spheres that gradually release the drug as the polymer degrades — a proven technology (Risperdal Consta, Lupron Depot) but one that takes years to develop with traditional methods. Eli Lilly's participation as an investor signals pharma validation of the platform approach.\n\nIn 2025, Persist AI competes in the drug formulation and CDMO (contract development and manufacturing) market with EVO Pharma, Polymeropoulos (a long-acting injectable specialist), and larger CDMOs including Lonza and Catalent for LAI microsphere development services. The long-acting injectable market is growing as mental health conditions (schizophrenia, bipolar) see improved outcomes with LAI antipsychotics that eliminate the adherence problem — patients who receive monthly or quarterly injections have significantly better medication compliance than those taking daily pills. The 2025 strategy focuses on growing pharma company partnerships for LAI development projects, advancing internal pipeline candidates toward clinical trials, and building the manufacturing scale-up capabilities needed for commercial supply.
Tech-enabled bookkeeping pairing dedicated accountants with proprietary automation; flat monthly subscription; founded 2020 in Fishers, Indiana; faster close with full client transparency.
About
Decimal is a Fishers, Indiana-based technology-enabled bookkeeping company that provides small businesses with a dedicated accounting team and a modern software platform for a flat monthly subscription. Founded in 2020, Decimal was built to address the most common frustration of small business owners who have outgrown DIY bookkeeping but find traditional bookkeeping firms slow, expensive, and opaque. Decimal pairs each client with a dedicated bookkeeper and accounting team who are supported by proprietary software that automates routine transaction processing, exception identification, and reporting, allowing the human team to focus on accuracy review, month-end close, and client communication rather than manual data entry.\n\nDecimal's product experience centers on transparency and responsiveness. Clients access their books through a web portal with real-time financial dashboards showing cash position, profit and loss, and accounts receivable and payable balances. The platform includes a communication thread for each question or task, giving small business owners visibility into the status of their bookkeeping without email chains or phone tag. Decimal's pricing model is a flat monthly subscription based on business complexity rather than hours worked, making costs predictable and removing the billing anxiety that characterizes traditional bookkeeping relationships.\n\nDecimal targets small businesses with $500,000 to $10 million in annual revenue that need accurate, timely books and periodic financial guidance but are not yet ready for a full-time accounting hire or a CFO-level engagement. The company operates as a fully remote team and serves clients across the United States in industries including professional services, e-commerce, retail, and service businesses. Decimal competes with Bench, Pilot, and Botkeeper in the technology-enabled bookkeeping market, differentiating on its dedicated team model, the quality of its software-plus-human integration, and its Midwestern operational roots that keep its cost structure competitive.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.